PMID- 21454378 OWN - NLM STAT- MEDLINE DCOM- 20110830 LR - 20211020 IS - 1557-3125 (Electronic) IS - 1541-7786 (Linking) VI - 9 IP - 5 DP - 2011 May TI - Role of fibulin-5 in metastatic organ colonization. PG - 553-63 LID - 10.1158/1541-7786.MCR-11-0093 [doi] AB - The tumor microenvironment is now recognized as a major factor in determining the survival and growth of disseminated tumor cells at potential metastatic sites. Tumor cells send signals to stroma cells and stimulate them to produce factors that in turn create favorable conditions for tumor cell metastasis. Activated fibroblasts constitute an important component of the tumor-associated stroma. We have previously shown that S100A4 protein produced by stromal fibroblasts in the primary tumor stimulates metastasis formation. Here we show that activated fibroblasts also stimulate the formation of metastases independently of S100A4 expression during organ colonization. To identify genes that could potentially interfere with fibroblast-driven metastasis, we used gene expression profiling of S100A4-deficient fibroblasts treated with and without tumor cell-conditioned media. Five differentially expressed genes encoding cell surface and secreted proteins with potential metastasis-modulating activity were selected. Expression of lymphocyte antigen 6 complex (Ly6c) and matrix metalloproteinase 3 (Mmp3) was upregulated in fibroblasts in response to tumor-conditioned medium, whereas expression of cadherin-16 (Cdh16), Ccn2, and fibulin-5 (Fbln5) was downregulated. Further analysis showed that Fibulin-5 is able to suppress the metastatic colonization of lungs and liver. Additional studies suggest a mechanism in which Fibulin-5 suppresses metastasis formation by inhibiting production of matrix metalloproteinase 9 (MMP9) and reducing the invasive behavior of fibroblasts. Together our data are consistent with the notion that tumors secrete factors that downregulate expression of Fbln5 in fibroblasts at sites of metastatic colonization, in turn upregulating Mmp9 expression and stimulating metastatic organ colonization. FAU - Moller, Henrik Devitt AU - Moller HD AD - Department of Tumor Microenvironment and Metastasis, Danish Cancer Society, Strandboulevarden 49, DK-2100 Copenhagen, Denmark. FAU - Ralfkjaer, Ulrik AU - Ralfkjaer U FAU - Cremers, Natascha AU - Cremers N FAU - Frankel, Mika AU - Frankel M FAU - Pedersen, Rune Troelsgaard AU - Pedersen RT FAU - Klingelhofer, Jorg AU - Klingelhofer J FAU - Yanagisawa, Hiromi AU - Yanagisawa H FAU - Grigorian, Mariam AU - Grigorian M FAU - Guldberg, Per AU - Guldberg P FAU - Sleeman, Jonathan AU - Sleeman J FAU - Lukanidin, Eugene AU - Lukanidin E FAU - Ambartsumian, Noona AU - Ambartsumian N LA - eng GR - R01 HD064824/HD/NICHD NIH HHS/United States GR - R01 HL106305/HL/NHLBI NIH HHS/United States PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20110331 PL - United States TA - Mol Cancer Res JT - Molecular cancer research : MCR JID - 101150042 RN - 0 (Antigens, Ly) RN - 0 (CCN2 protein, mouse) RN - 0 (Cadherins) RN - 0 (Cdh16 protein, mouse) RN - 0 (Culture Media, Conditioned) RN - 0 (Extracellular Matrix Proteins) RN - 0 (FBLN5 protein, human) RN - 0 (Ly6 protein, mouse) RN - 139568-91-5 (Connective Tissue Growth Factor) RN - EC 3.4.24.17 (Matrix Metalloproteinase 3) RN - EC 3.4.24.35 (Matrix Metalloproteinase 9) SB - IM MH - Animals MH - Antigens, Ly/drug effects/metabolism MH - Cadherins/drug effects/metabolism MH - Cell Line, Tumor MH - Connective Tissue Growth Factor/drug effects/metabolism MH - Culture Media, Conditioned/pharmacology MH - Down-Regulation MH - Extracellular Matrix Proteins/drug effects/*metabolism MH - Fibroblasts/drug effects/*metabolism MH - *Gene Expression Regulation, Neoplastic MH - Liver Neoplasms/genetics/*secondary MH - Lung Neoplasms/genetics/*secondary MH - Matrix Metalloproteinase 3/drug effects/metabolism MH - Matrix Metalloproteinase 9/drug effects/*metabolism MH - Mice EDAT- 2011/04/02 06:00 MHDA- 2011/08/31 06:00 CRDT- 2011/04/02 06:00 PHST- 2011/04/02 06:00 [entrez] PHST- 2011/04/02 06:00 [pubmed] PHST- 2011/08/31 06:00 [medline] AID - 1541-7786.MCR-11-0093 [pii] AID - 10.1158/1541-7786.MCR-11-0093 [doi] PST - ppublish SO - Mol Cancer Res. 2011 May;9(5):553-63. doi: 10.1158/1541-7786.MCR-11-0093. Epub 2011 Mar 31.